Trial reportJournal of midwifery & women's health
Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Menstrual Symptoms in Primary Dysmenorrhea: A Placebo-Controlled Study.
Trial report in Journal of midwifery & women's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06741059 (Determining the Effect of Transcutaneous Electrical Nerve Stimulation), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Determining the Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Pain and Menstrual Symptoms in Primary Dysmenorrhea
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPrimary dysmenorrhea, with a prevalence of 45% to 95%, is a common gynecological condition that significantly affects women's daily functioning and quality of life.
methodsThis randomized, single-masked study compared the effects of transcutaneous electrical nerve stimulation (TENS) on pain intensity and menstrual symptoms in women with primary dysmenorrhea using a 3-arm design including TENS (n = 31), placebo (n = 31), and no-intervention control (n = 31) groups. TENS was administered in two 20-minute sessions on the same day during the first 3 days of menstruation. Pain intensity was measured using the Visual Analog Scale (VAS), and menstrual symptoms were assessed with the Daily Menstrual Symptom Rating (DMSR) scale. Between-group differences in postintervention outcomes were analyzed using analysis of covariance, adjusting for baseline values. The trial was prospectively registered at ClinicalTrials.gov (NCT06741059).
resultsAfter baseline adjustment, significant between-group differences were observed in pain intensity and menstrual symptoms. Adjusted posttest VAS scores were lowest in the TENS group, followed by the placebo group and the control group (P < .001), with a large effect size (partial η DISCUSSION: TENS represents a safe, accessible, and patient-centered option for short-term menstrual pain management beyond placebo effects in primary dysmenorrhea.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.